Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis

被引:373
作者
Shirogane, T
Fukada, T
Muller, JMM
Shima, DT
Hibi, M
Hirano, T
机构
[1] Osaka Univ, Grad Sch Med, Div Mol Oncol, Ctr Biomed Res, Suita, Osaka 5650871, Japan
[2] Imperial Canc Res Fund, Cell Biol Lab, London WC2A 3PX, England
关键词
D O I
10.1016/S1074-7613(00)80145-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The activation of STAT3 by the cytokine receptor gp130 is required for both the G1 to S cell cycle transition and antiapoptosis. We found that Pim-l and Pim-2 are targets for the gp130-mediated STAT3 signal. Expression of a kinase-defective Pim-1 mutant attenuated gp130-mediated cell proliferation. Constitutive expression of Pim-l together with c-myc, another STAT3 target, fully compensated for loss of the STAT3-mediated cell cycle progression, antiapoptosis, and bcl-2 expression. We also identified valosine-containing protein (VCP) as a target gene for the Pim-1-mediated signal. Expression of a mutant VCR led cells to undergo apoptosis. These results indicate that Rim-family proteins play crucial roles in gp130-mediated cell proliferation and explain the synergy between Rim and c-Myc proteins in cell proliferation and lymphomagenesis.
引用
收藏
页码:709 / 719
页数:11
相关论文
共 66 条
  • [1] Functional roles of STAT family proteins: Lessons from knockout mice
    Akira, S
    [J]. STEM CELLS, 1999, 17 (03) : 138 - 146
  • [2] Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc
    Allen, JD
    Verhoeven, E
    Domen, J
    vanderValk, M
    Berns, A
    [J]. ONCOGENE, 1997, 15 (10) : 1133 - 1141
  • [3] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [4] Besser D, 1999, MOL CELL BIOL, V19, P1401
  • [5] APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2
    BISSONNETTE, RP
    ECHEVERRI, F
    MAHBOUBI, A
    GREEN, DR
    [J]. NATURE, 1992, 359 (6395) : 552 - 554
  • [6] VERY HIGH-FREQUENCY OF LYMPHOMA INDUCTION BY A CHEMICAL CARCINOGEN IN PIM-1 TRANSGENIC MICE
    BREUER, M
    SLEBOS, R
    VERBEEK, S
    VANLOHUIZEN, M
    WIENTJENS, E
    BERNS, A
    [J]. NATURE, 1989, 340 (6228) : 61 - 63
  • [7] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [8] Stat3 activation is required for cellular transformation by v-src
    Bromberg, JF
    Horvath, CM
    Besser, D
    Lathem, WW
    Darnell, JE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) : 2553 - 2558
  • [9] Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
    Carlesso, N
    Frank, DA
    Griffin, JD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 811 - 820
  • [10] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    [J]. IMMUNITY, 1999, 10 (01) : 105 - 115